B-cell Lymphoma: 2742 Clinical Trials, Page 269 of 275

« First Page «…5 10 15 …267 268 269 270 271 …275 … »Last Page »

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Condition(s):B Acute Lymphoblastic Leukemia; Mantle Cell Lymphoma; Follicular LymphomaLast Updated:December 3, 2019Unknown status

2682

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

Condition(s):Follicular Lymphoma; ALL; NHL; Large Cell LymphomaLast Updated:May 23, 2023Recruiting

2683

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

Condition(s):Acute Lymphocytic Leukemia; LymphomaLast Updated:January 4, 2023Active, not recruiting

2684

Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Condition(s):Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic LymphomaLast Updated:November 11, 2015Terminated

2685

Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies

Condition(s):B Cells-Tumors; B Cell Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Large B-Cell Diffuse Lymphoma of Bone (Diagnosis)Last Updated:November 10, 2022Terminated

2686

A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL

Condition(s):Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Mantle Cell LymphomaLast Updated:March 10, 2023Active, not recruiting

2687

A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

Condition(s):Acute Lymphoblastic Leukemia; Non-Hodgkin’s LymphomaLast Updated:February 21, 2020Recruiting

2688

Combination Chemotherapy in Treating Patients With Non-Hodgkin’s Lymphoma or Acute Lymphocytic Leukemia

Condition(s):Leukemia; LymphomaLast Updated:August 21, 2013Completed

2689

Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin’s Lymphoma or Acute Lymphoblastic Leukemia

Condition(s):Leukemia; LymphomaLast Updated:July 25, 2014Completed

2690

CART19 Cells Effects in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma

Condition(s):Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia; Non-Hodgkin’s Lymphoma Refractory; Non-Hodgkin’s Lymphoma, RelapsedLast Updated:August 4, 2022Recruiting

« First Page «…5 10 15 …267 268 269 270 271 …275 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.